Your money for a run? Campaign finance in America

Your money for a run? Campaign finance in Ame...

Up next

First rate: Kevin Warsh’s Fed debut

As expected, the new Federal Reserve chairman kept rates steady. More interesting were what he did and did not say. How will he handle inevitable pressure from President Donald Trump? After nearly disappearing altogether, Germany’s left-wing Die Linke party is roaring back—partic ...  Show more

View from the summit: what did the G7 achieve?

Geopolitics has dominated this year’s G7 political meeting in Evian, France. Donald Trump offered scant detail on the Iran peace deal but leaders promised to boost support for Ukraine. Though prostitution in Japan has a long history, recent scandals have drawn it into the spotlig ...  Show more

Recommended Episodes

Your money for a run? Campaign finance in America
Economist Podcasts

Kamala Harris has proven to be an enormous draw for campaign donors. But the size of a candidate’s war chest influences the outcome much less than it once did. Our correspondent meets asylum-seekers on a Dutch ship, investigating the new hard-right government’s tactics with migra ...  Show more

Last-ditch pitch: America’s campaigns conclude
Economist Podcasts

Both campaigns have racked up air miles covering the swing states that will decide America’s knife-edge election. We take a measure of things one day before the vote. The Turkic states of central Asia once depended heavily on Russia; now they are banding together to counterbalanc ...  Show more

Keep Kamala and carry on: Harris’s smooth route
Economist Podcasts

A day is a long time in American politics: Kamala Harris has reportedly already secured the votes to become Democrats’ presidential nominee, a pile of campaign cash and the Trump campaign’s attention. For insight into how China treats its startup scene, we count the dwindling num ...  Show more

Don wan: Harris keeps Trump tame
Economist Podcasts

The vice-president turned in a confident if imperfect performance, leaving Donald Trump flustered. But will it change anything? A global shortfall of blood plasma is hampering the development of new medicines; we argue for some simple market forces that could plug the gap (11:40) ...  Show more